Elite Pharmaceuticals, Inc. Restricted Cash and Cash Equivalents
Elite Pharmaceuticals, Inc. (ELTP) had Restricted Cash and Cash Equivalents of $405.16 thousand as of 2022-06-30, per its 10-Q filed 2022-08-15.
Discontinued › Balance Sheet › Assets › Restricted Cash and Cash Equivalent
us-gaap:RestrictedCashAndCashEquivalents · last filed 2022-08-15
- 2022-06-30: Restricted Cash and Cash Equivalents $405.16K.
- 2022-03-31: Restricted Cash and Cash Equivalents $405.04K.
- 2021-12-31: Restricted Cash and Cash Equivalents $405.03K.
- 2021-09-30: Restricted Cash and Cash Equivalents $405.02K.
| Period end | Restricted Cash and Cash Equivalents |
|---|---|
| 2022-06-30 | $405.16K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $405.04K 10-Q · filed 2022-08-15 |
| 2021-12-31 | $405.03K 10-Q · filed 2022-02-14 |
| 2021-09-30 | $405.02K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $405.01K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $405.01K 10-K · filed 2022-06-29 |
| 2020-12-31 | $405.00K 10-Q · filed 2021-02-16 |
| 2020-09-30 | $404.99K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $404.99K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $404.80K 10-K · filed 2021-06-14 |
| 2019-12-31 | $403.57K 10-Q · filed 2020-02-10 |
| 2019-09-30 | $401.47K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $398.13K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $398.13K 10-K · filed 2020-06-29 |
| 2018-12-31 | $396.13K 10-Q · filed 2019-02-11 |
| 2018-09-30 | $394.40K 10-Q · filed 2018-11-09 |
| 2018-06-30 | $392.82K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $391.57K 10-K · filed 2019-06-21 |
| 2017-12-31 | $390.65K 10-Q · filed 2018-02-09 |
| 2017-09-30 | $390.01K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $389.39K 10-Q · filed 2017-08-09 |
| 2017-03-31 | $389.08K 10-K · filed 2018-06-14 |
| 2016-12-31 | $388.96K 10-Q · filed 2017-02-09 |
| 2016-09-30 | $388.96K 10-Q · filed 2016-11-09 |
| 2016-06-30 | $388.96K 10-Q · filed 2016-08-09 |
| 2016-03-31 | $388.96K 10-K · filed 2017-06-14 |